Pamprin Cramp Menstrual Pain Relief (acetaminophen / magnesium salicylate / pamabrom) Drug Interactions
A total of 360 drugs are known to interact with Pamprin Cramp Menstrual Pain Relief (acetaminophen / magnesium salicylate / pamabrom).
- 21 major drug interactions
- 274 moderate drug interactions
- 65 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Pamprin Cramp Menstrual Pain Relief (acetaminophen / magnesium salicylate / pamabrom) and the medicines listed below.
- Abilify (aripiprazole)
- Abreva (docosanol topical)
- acetaminophen
- Acidophilus (lactobacillus acidophilus)
- Aciphex (rabeprazole)
- Actemra (tocilizumab)
- Adderall XR (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- albuterol
- allantoin / camphor / phenol topical
- Ambien CR (zolpidem)
- amlodipine
- cetirizine
- Flax Seed Oil (flax)
- hydroxyzine
- levothyroxine
- loratadine
- MiraLAX (polyethylene glycol 3350)
- multivitamin with iron
- Tylenol Extra Strength (acetaminophen)
Pamprin Cramp Menstrual Pain Relief (acetaminophen / magnesium salicylate / pamabrom) alcohol/food interactions
There is 1 alcohol/food interaction with Pamprin Cramp Menstrual Pain Relief (acetaminophen / magnesium salicylate / pamabrom)
Pamprin Cramp Menstrual Pain Relief (acetaminophen / magnesium salicylate / pamabrom) disease interactions
There are 13 disease interactions with Pamprin Cramp Menstrual Pain Relief (acetaminophen / magnesium salicylate / pamabrom) which include:
- alcoholism
- liver disease
- GI toxicity
- renal dysfunction
- Reye's syndrome
- PKU
- hypermagnesemia
- hypokalemia
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
More about Pamprin Cramp Menstrual Pain Relief (acetaminophen / magnesium salicylate / pamabrom)
- Side Effects
- Imprints, Shape & Color Data
- En Español
- Drug class: analgesic combinations
- FDA Alerts (2)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.